Alcon sank -2.2% this morning, compared to the S&P 500's day change of 1.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:
-
Alcon has logged a 21.3% 52 week change, compared to 26.3% for the S&P 500
-
ALC has an average analyst rating of buy and is -2.93% away from its mean target price of $101.47 per share
-
Its trailing earnings per share (EPS) is $2.22, which brings its trailing Price to Earnings (P/E) ratio to 44.4. The Health Care sector's average P/E ratio is 27.61
-
The company's forward earnings per share (EPS) is $3.52 and its forward P/E ratio is 28.0
-
The company has a Price to Book (P/B) ratio of 2.33 in contrast to the Health Care sector's average P/B ratio is 3.69
-
The current ratio is currently 2.3, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
ALC has reported YOY quarterly earnings growth of 32.4% and gross profit margins of 0.6%
-
The company's free cash flow for the last fiscal year was $1.39 Billion and the average free cash flow growth rate is 6.1%
-
Alcon's revenues have an average growth rate of 5.2% with operating expenses growing at 2.6%. The company's current operating margins stand at 11.0%